A case-control analysis of 95 Turkish participants age around 40 years conducted by Yasar Colak revealed that Lp-PLA2 levels are higher in NAFLD patients than in healthy controls13. Here, PLA2G7 is linked to metabolic dysfunction-associated steatotic liver disease.